Dr. Nasir M. Idkaidek,
College of Pharmacy & Medical Sceinces,
University of Petra, Amman, Jordan.

Dr. Antoine Malek, University Hospital Zurich,
Department of Obstetrics, Research Division,
Frauenklinikstr. 10, 8091 Zurich, Switzerland.

Title: Inter-individual Variability and Drug Development: BA/BE as Research Tool
Dr. Harish Padh, Director, B. V. Patel Perd Centre,
Thaltej-gandhinagar highway, Thaltej, Ahmedabad, India.

Title: Bioavailability Enhancement of Ropinirole by Using Nanoemulsion Based System
Dr. Sushama Talegaonkar, Department of Pharmaceutics,
Faculty of Pharmacy, Jamia Hamdard, New Delhi-110062, India.

Title: The Importance of the Human Placenta Ex Vivo Perfusion Model in the Drug Development for Human Pregnancy
Dr. Antoine Malek, University Hospital Zurich,
Department of Obstetrics, Research Division,
Frauenklinikstr. 10, 8091 Zurich, Switzerland.

9:50-10:15

Title: Enhancement of Oral Bioavailability of Insulin in Humans
Dr. Nasir M. Idkaidek,
College of Pharmacy & Medical Sceinces,
University of Petra, Amman, Jordan.

Title: Drug Discovery from Natural Toxins and on Animal models
Dr. P.Gopalakrishnakone,
President, International Society on Toxinology,
Department of Anatomy & Venom and Toxin Research Programme,
Yong Loo Lin School of Medicine, National University of Singapore,
Lower Kent Ridge Road, Singapore.

Title: Human/Animal Models in Oral Drug Absorption
Dr. Ercument Karasulu, Assoc.Professor, Ege University,
Center for Drug R&D and Pharmacokinetic Applications,
35100 Bornova, IZMIR, Turkey.

Dr. David Goldsmith, Renal Unit, New Guy House, 
Guy's Hospital, London, UK.

Dr. Khalid Alkharfy,College of Pharmacy,
King Saud University, Riyadh, Saudi Arabia.

Title:  Biosimilar Products Selection: Challenges for Clinicians
Dr. Khalid Alkharfy,College of Pharmacy,
King Saud University, Riyadh, Saudi Arabia.

Title: Drug Delivery in Pregnancy: Transport of Nanoparticles Across the Human Placenta and Fetal Exposure
Dr. Antoine Malek, University Hospital Zurich,
Department of Obstetrics, Research Division,
Frauenklinikstr. 10, 8091 Zurich, Switzerland.

Title: European Regulations in the Context of Biosimilars
Dr. Jean-Louis Prugnaud, Chef de Service,
Hôpital Saint-Antoine, 184 rue du Fbg Saint-Antoine,
Paris.

Title: Biosimilars and CHMP EU Scientific Aadvice
Dr. Efthymios Manolis, Scientific Administrator,
Scientific Advice Human - Pre Authorisation Evaluation, EMEA,
7 Westferry Circus, Canary Wharf, London, UK.

Title: Biosimilar of Epoetin Alfa: Issues on Comparability and Immumogenicity
Dr. Lucia Del Vecchio, 
Department of Nephrology and Dialysis,
A. Manzoni Hospital, Lecco, Italy.

Title: Biosimilars and Follow-on Biologics
Dr. Fuhr Joseph P, Widener University, One University Place, Chester, PA 19013, USA.

Title: Biosimilar Epoetins in Europe - A Success Story?
Dr. David Goldsmith, Renal Unit, New Guy House,
Guy's Hospital, London, UK.

Dr. Srinubabu Gedela,
Stanford University School of Medicine, USA.

Prof. Hany A. El-Shemy, Director of Biotechnology Labs,
FARP, Biochemistry and Molecular Biology,
Biochemistry Department, Faculty of Agriculture,
Cairo University, 12613 Giza, Egypt.

Title: In-Silico Selection of Natural Anti-leukaemia Compounds
Prof. Hany A. El-Shemy, Director of Biotechnology Labs,
FARP, Biochemistry and Molecular Biology,
Biochemistry Department, Faculty of Agriculture,
Cairo University, 12613 Giza, Egypt.

Title: In Silico Adme Prediction Using QSPR Studies
Dr. Yash Paul Singla,
Principal, Lord Shiva College of Pharmacy,
P.B. No.63, Near Civil Hospital, Sirsa-125055, Haryana, India.

Dr. Hsin-Yun HSU, Laboratory of Medical Genomics,
Department of Human Genome Research,
Kazusa DNA Research Institute, Kisarazu, Chiba, Japan.

Dr. Alexey Goltsov, Centre for Systems Biology of Edinburgh,
School of Biological Sciences, University of Edinburgh,
The Kings Buildings, Mayfield Road, Edinburgh, EH9 3JU, UK.

Title: Drug Delivery System for Proteins and Biosimilars
Dr. Sathy V. Balu-Iyer, Associate Professor,
Department of Pharmaceutical Sciences, 521 Hochstetter Hall,
University at Buffalo, State University of New York,
Amherst, New York, USA.

Prof. Kwang-il Kwon, College of Pharmacy,
Chungnam National University, Daejeon, Korea.

Ms. Ying Grace Li, Project Statistician
Statistics-AI/ MSK/ CC/ CV, Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285, USA.

Title: Bioequivalence Methods for Assessment of Highly
Variable Drug – ABE, SABE, PBE and IBE
Prof. Kwang-il Kwon, College of Pharmacy,
Chungnam National University, Daejeon, Korea.

Title: The Application of Bayesian/Frequentist Analysis in Bioequivalence/Bioavailability Studies
Ms. Ying Grace Li, Project Statistician,
Statistics-AI/ MSK/ CC/ CV, Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285, USA.

Title: Sparse Sampling Strategies in Pharmacokinetics and Bioequivalence
Dr. Shubha Rani,
Technical Director & Head - Biometrics and Data Management,
Synchron Research Services Pvt. Ltd.,
'The chambers', 3rd Floor, Bodakdev, SG Highway,
Ahmedabad, India.

Dr. Isadore Kanfer, Emeritus Professor, Faculty of Pharmacy,
Rhodes University, Grahamstown, South Africa.

Dr. Luis Pereira, Associate Professor,
Pharmacometrics MCPHS, Childrens' Hospital Boston,
Harvard Medical School, Boston, MA, USA.

Title: Average, Individual and Population Bioequivalence – Understanding the True Variability of a Product
Dr. Bhaswat S. Chakraborty , Sr. Vice President, R&D,
Cadila Pharmaceuticals, India.

Title: Bioavailability of  Flavonoids: In Vitro Methods for Assessing Bilitranslocase-Mediated Membrane Transport
Dr. Sabina Passamonti, University of Trieste,
Department of Life Sciences, via L. Giorgieri 1, 34127 Trieste,
Italy.

Title: Quantitation of Alpha Amyrin in Scoparia dulcis L. Whole Plant Extract by High Performance Liquid Chromatography
Dr. Kishore Kumar Kadimpati, Dept. Of Plant Sciences,
School of Life Sciences, University of Hyderabad, Gochibowli,
Hyderabad, India.

Title: Application of Dermal Microdialysis for the Determination of Bioavailability/Bioequivalence of Topical Drug Products Not Intended for Systemic Circulation
Dr. Isadore Kanfer, Emeritus Professor, Faculty of Pharmacy,
Rhodes University, Grahamstown, South Africa.

Dr. Luis Pereira, Associate Professor,
Pharmacometrics MCPHS, Childrens' Hospital Boston,
Harvard Medical School, Boston, MA, USA.

Dr. Praveen S. Hiremath, Pharmaceutics Int., Inc., USA.

Dr. Mansoor A. Khan,
Director, Division of Product Quality Research,
FDA/CDER/OPS/OTR, White Oak, LS Building 64,
10903 New Hampshire Ave, Silver Spring, MD, USA.

Title: Role of Lipid Based Drug Delivery Systems in Bioavailability Enhancement
Dr. Praveen S. Hiremath, Product Development,
Pharmaceutics International, Inc., 10189 Gilroy Road,
Hunt Valley, MD, USA.

Dr. Mansoor A. Khan,
Director, Division of Product Quality Research,
FDA/CDER/OPS/OTR, White Oak, LS Building 64,
10903 New Hampshire Ave, Silver Spring, MD, USA.

Title: Bioavailability and Bioequivalence of Novel Drug Delivery Systems
Dr. N. Udupa, Professor and Principal,
College of Pharmaceutical Sciences, MAHE, Manipal, India.

Title: Nanosuspensions for Improved Drug Bioavailability and Targeted Drug Delivery
Prof. Kamalinder.K.Singh,
Principal(Addl. Charge), C.U.Shah College Of Pharmacy,
SNDT Women's University, Santacruz (West),
Mumbai - 400049, India.

Dr. Rajeev Raghuvanshi,

Title: Enhancing Oral Bioavailabilty of Drugs Using Cyclodextrins
Dr. B.S.Kuchekar, Maharashtra Institute of Pharmacy,
MIT Campus, Paud Road, Kothrud, Pune. Maharashtra, India.

Dr. Ajit Srivastava
Business Manager - LCMS, Agilent Technologies India Pvt. Ltd,
Plot No 10, Udyog Vihar, Phase IV, Gurgaon – 122016, India.

Dr. S. Ravisankar, PhD, MBA,
Director, Quality Assurance, Clinical Development,
GVK Biosciences Pvt Ltd, India.

Title: Recent Developments in Bioanalytical Method Validation Requirements for Mass Spectrometric Methods
Dr. S. Ravisankar, PhD, MBA,
Director, Quality Assurance, Clinical Development,
GVK Biosciences Pvt Ltd, India.

Dr. Ajit Srivastava
Business Manager - LCMS, Agilent Technologies India Pvt. Ltd,
Plot No 10, Udyog Vihar, Phase IV, Gurgaon – 122016, India.

Title: Bioanalytical Method Transfer: Challenges and Recent Developments
Dr.Yarramraju Sitaramaraju, Associate director,
Clinical Development, Aizant Drug Research Solutions P. Ltd.,
Hyderabad, India.

Title: Ion Trap as a Tool for In-vitro and In-vivo Metabolite Profiling
Dr. Girish kumar jain,
Head, Division of Pharmacokinetics & Metabolism,
Central Drug Research Institute, Lucknow-226001, India.

Title: Bioanalytical Methodology Development and Validation Using HPLC and LCMS-Advances in Mass Spectrometry Methodology Development
Dr. Constantinos Pistos, Lecturer of Toxicology,
Laboratory of Forensic Medicine and Toxicology,
Medical School, University of Athens, Greece.

Title: Bioanalytical Method Development of the Metabolite 3-desmethylthiocolchicine in Human Plasma by LC-MS/MS
Dr. Sangita Agarwal, Women Scientist-DST,
Dept. of Pharm. Tech., Jadavpur University, Kolkata, India.

Dr. Silvia Lima Costa,
Laboratorio de Neuroquimica e Biologia Celular,
Universiade Federal da Bahia, Instituto de Ciências da Saude, Brazil.

13:30-13:55

Title: Protection against Seasonal and Avian Influenza Virus Infections Using Nucleic Acid-Based Antiviral Agents
Dr. Jonathan P. Wong, Defence Scientist,
Defence Research and Development Canada, Suffield,
CP 4000, Succ. Main, Medicine Hat, Alberta, Canada.

13:55-14:20

Title: Biochemical and Biological Studies on Salt Stressed Spirulina Platensis
Dr. Emad A. Shalaby,
Biochemistry Department, Faculty of Agriculture and
Botany Department, Faculty of Science, Cairo University,
Giza, Egypt.

Title: The Necessity of New Sinergistic Formulations to Combat the Drug Resistance
Dr. Henrique Douglas Coutinho,
Laboratory of Microbiology and Molecular Biology,
Depart. of Biological Sciences,
University of Region of Cariri - URCA, AV. Cel Antonio Luiz,
Crato (CE), Brazil.

16:20-16:45

Title: Standardization of Herbal Drug Preparations using LC-MS
Dr. Jawahar Lal, Scientist E-II,
Pharmacokinetics & Metabolism Division,
Central Drug Research Institute, CSIR, Lucknow, India.

Dr. Mohammadreza Ghandforoush-Sattari,
Assistant Professor of Clinical Toxicology,
Dept.Pharmacology & Toxicology, Faculty of Pharmacy,
Tabriz University of Medical Sciences, Tabriz, Iran.

Dr. Raphael Serreau, MD, Responsable Appel d'Offre - PV,
URC Paris Necker-Cochin- EA 3620, Hopital Cochin, Paris.

Title: Bioequivalence of generic antiepilepsy drugs
Dr. Gregory Krauss, MD, Professor of Neurology,
Johns Hopkins University, Baltimore, MD, USA.

9:25-9:50

Title: Codeine and Breastfeeding, What are the Latest Data in Pharmacovigilance and EMEA Regulation
Dr. Raphael Serreau, MD, Responsable Appel d'Offre - PV,
URC Paris Necker-Cochin- EA 3620, Hopital Cochin, Paris.

Dr. S. Chattopadhyay

Dr. Darshak Karia, MD, Director, Heart Failure Services,
Einstein Heart and Vascular Institute, Levy 3 East,
Albert Einstein Medical Center, Philadelphia, USA.

Title: Clinical Study of the Bioequivalence of Trimetazidine Immediate Release and Modified Release Tablets
Dr. Dilek Erol, Yeditepe University, Faculty of Pharmacy, 34755 Kayısdagı, Istanbul, Turkey.

Session Chair:

Prof. P. Reddanna,
Eicosanoids, Inflammation & Cancer Research Group,
School of Life Sciences, University of Hyderabad, Hyderabad, India.

Session Co-Chair:

Dr. Sudhakar Akulapalli, Creighton University Medical Center and University of Nebraska Medical Center.
Director & Coordinator: Cell Signaling and Tumor Angiogenesis Laboratory, Boys Town National Research Hospital, Omaha, USA.

13:05-13:30

Title: Design of New Drug Molecules to be Used in Reversing Multidrug Resistance in Cancer Cells
Prof. Mayur Yergeri, Department of Medicinal Chemistry,
V.L. College of Pharmacy, Raichur, India.

13:30-13:55

Title: Signaling Mechanisms of Endogenous Anti-cancer Molecules Derived From Extra Cellular Matrix Type IV Collagen
Dr. Sudhakar Akulapalli, Creighton University Medical Center and University of Nebraska Medical Center.
Director & Coordinator: Cell Signaling and Tumor Angiogenesis Laboratory, Boys Town National Research Hospital, Omaha, USA.

Title: Expanding Applications for Use of Biologically Modified Nanoparticles in Cancer Research
Dr. Eric Michael Bratsolias Brown, Assistant Professor,
Department of Biological Sciences,
University of Wisconsin-Whitewater, Upham Hall,
800 W. Main St., Whitewater, WI 53190, USA.

14:20-14:45

Title: Imatinib Resistance in Chronic Myeloid Leukemia:
Role of COX-2, MDR-1 and HDACs
Prof. P. Reddanna,
Eicosanoids, Inflammation & Cancer Research Group,
School of Life Sciences, University of Hyderabad, Hyderabad, India.

16:20-16:45

Title: Phosphorylation of eIF2α-Mediated Signalling Pathways in Cell Survival and Suicide
Prof. Kolluru VA Ramaiah, Dept of Biochemistry,
School of Life Sciences, University of Hyderabad
Hyderabad, India.

16:45-17:10

Title: Differential Regulation of HIF-1α under Normoxic and Hypoxic Conditions 
Dr. Surya S. Singh, Dept. of Biochemistry,
Osmania University, Hyderabad, India.

Prof. Mario Giorgi, Pharmacology & Toxicology Section,
University of Pisa, V.le delle Piagge 2, 56124 Pisa, Italy.

Session Co-Chair:

Prof. Basavaraj K. Nanjwade, Department of Pharmaceutics,
JN Medical college, KLE University, Belgaum- 590010,
Karnataka, India.

13:30-13:55

Title: PK-PD integration/modeling of NSAID in Veterinary Pharmacology
Prof. Mario Giorgi, Pharmacology & Toxicology Section,
University of Pisa, V.le delle Piagge 2, 56124 Pisa, Italy.

16:20-16:45

Title: Regulatory Requirements for Orphan Drugs Delivery
Prof. Basavaraj K. Nanjwade, Department of Pharmaceutics,
JN Medical college, KLE University, Belgaum- 590010,
Karnataka, India.

Ms. Neerja S, Dy. Manager, QA, RA Chem Pharma Ltd,
Clinical Research and Biosciences division,
C3 (A) HUDA complex, Tarnaka, Hyderabad, India.

Dr. Pralhad Tayade, DGM Contract Research,
Raptakos Brett & Co., Mumbai, India.

13:05-13:30

Title: Assuring Bioequivalence: Pilot Studies or Dissolution?
Dr. Ranjani Nellore, RAC, PharMantra Consulting Solutions,
Hyderabad, India.

Title: Challenges for Preparation of Module 2 & 5 for BA/ BE for US & EMEA
Ms. Neerja S, Dy. Manager, QA, RA Chem Pharma Ltd,
Clinical Research and Biosciences division,
C3 (A) HUDA complex, Tarnaka, Hyderabad, India.

Title: What Should be Indian Pharma R&D’s Focus Areas in 2010
Dr. Pralhad Tayade, DGM Contract Research,
Raptakos Brett & Co., Mumbai, India.

Title: In-Vitro Release and Pharmacokinetics of Anti-tubercle
Drug Ethionamide in Healthy Male Subjects
Prof. Mahmaood Ahmad,
Dean, Faculty of Pharmacy and Alternative Medicine,
The Islamia University of Bahawalpur, Punjab, Pakistan.